223 related articles for article (PubMed ID: 21871014)
1. Nanoparticle-based cerebral drug-delivery systems and antiangiogenic approach in gliomas treatment.
Raudino G; Caffo M; Caruso G; Alafaci C; Tomasello F
Recent Pat Nanotechnol; 2011 Nov; 5(3):239-44. PubMed ID: 21871014
[TBL] [Abstract][Full Text] [Related]
2. Antisense oligonucleotides as innovative therapeutic strategy in the treatment of high-grade gliomas.
Caruso G; Caffo M; Raudino G; Alafaci C; Salpietro FM; Tomasello F
Recent Pat CNS Drug Discov; 2010 Jan; 5(1):53-69. PubMed ID: 19832690
[TBL] [Abstract][Full Text] [Related]
3. The blood-brain/tumor barriers: challenges and chances for malignant gliomas targeted drug delivery.
Zhan C; Lu W
Curr Pharm Biotechnol; 2012 Sep; 13(12):2380-7. PubMed ID: 23016643
[TBL] [Abstract][Full Text] [Related]
4. Targeted brain delivery nanoparticles for malignant gliomas.
Pinto MP; Arce M; Yameen B; Vilos C
Nanomedicine (Lond); 2017 Jan; 12(1):59-72. PubMed ID: 27876436
[TBL] [Abstract][Full Text] [Related]
5. Nanotechnology platforms in diagnosis and treatment of primary brain tumors.
Caruso G; Raudino G; Caffo M; Alafaci C; Granata F; Lucerna S; Salpietro FM; Tomasello F
Recent Pat Nanotechnol; 2010 Jun; 4(2):119-24. PubMed ID: 20415658
[TBL] [Abstract][Full Text] [Related]
6. Overcoming the blood-brain tumor barrier for effective glioblastoma treatment.
van Tellingen O; Yetkin-Arik B; de Gooijer MC; Wesseling P; Wurdinger T; de Vries HE
Drug Resist Updat; 2015 Mar; 19():1-12. PubMed ID: 25791797
[TBL] [Abstract][Full Text] [Related]
7. Patented nanomedicines for the treatment of brain tumors.
Caruso G; Raudino G; Caffo M
Pharm Pat Anal; 2013 Nov; 2(6):745-54. PubMed ID: 24237240
[TBL] [Abstract][Full Text] [Related]
8. Antisense oligonucleotides in the treatment of cerebral gliomas. Review of concerning patents.
Caruso G; Caffo M
Recent Pat CNS Drug Discov; 2014 Apr; 9(1):2-12. PubMed ID: 24605941
[TBL] [Abstract][Full Text] [Related]
9. Could nanoparticle systems have a role in the treatment of cerebral gliomas?
Caruso G; Caffo M; Alafaci C; Raudino G; Cafarella D; Lucerna S; Salpietro FM; Tomasello F
Nanomedicine; 2011 Dec; 7(6):744-52. PubMed ID: 21419873
[TBL] [Abstract][Full Text] [Related]
10. Nanoparticle Drug Delivery System for Glioma and Its Efficacy Improvement Strategies: A Comprehensive Review.
Li J; Zhao J; Tan T; Liu M; Zeng Z; Zeng Y; Zhang L; Fu C; Chen D; Xie T
Int J Nanomedicine; 2020; 15():2563-2582. PubMed ID: 32368041
[TBL] [Abstract][Full Text] [Related]
11. Drug delivery strategies for the treatment of malignant gliomas.
Allhenn D; Boushehri MA; Lamprecht A
Int J Pharm; 2012 Oct; 436(1-2):299-310. PubMed ID: 22721856
[TBL] [Abstract][Full Text] [Related]
12. MR image-guided delivery of cisplatin-loaded brain-penetrating nanoparticles to invasive glioma with focused ultrasound.
Timbie KF; Afzal U; Date A; Zhang C; Song J; Wilson Miller G; Suk JS; Hanes J; Price RJ
J Control Release; 2017 Oct; 263():120-131. PubMed ID: 28288892
[TBL] [Abstract][Full Text] [Related]
13. Nanoparticle-mediated drug delivery to high-grade gliomas.
Frosina G
Nanomedicine; 2016 May; 12(4):1083-1093. PubMed ID: 26767516
[TBL] [Abstract][Full Text] [Related]
14. Drug delivery strategies to enhance the permeability of the blood-brain barrier for treatment of glioma.
Zhang F; Xu CL; Liu CM
Drug Des Devel Ther; 2015; 9():2089-100. PubMed ID: 25926719
[TBL] [Abstract][Full Text] [Related]
15. Enhanced blood-brain barrier penetration and glioma therapy mediated by T7 peptide-modified low-density lipoprotein particles.
Liang M; Gao C; Wang Y; Gong W; Fu S; Cui L; Zhou Z; Chu X; Zhang Y; Liu Q; Zhao X; Zhao B; Yang M; Li Z; Yang C; Xie X; Yang Y; Gao C
Drug Deliv; 2018 Nov; 25(1):1652-1663. PubMed ID: 30394123
[TBL] [Abstract][Full Text] [Related]
16. Overcoming the Blood-Brain Barrier: Successes and Challenges in Developing Nanoparticle-Mediated Drug Delivery Systems for the Treatment of Brain Tumours.
Ferraris C; Cavalli R; Panciani PP; Battaglia L
Int J Nanomedicine; 2020; 15():2999-3022. PubMed ID: 32431498
[TBL] [Abstract][Full Text] [Related]
17. Endovascular therapies for malignant gliomas: Challenges and the future.
Su YS; Ali R; Feroze AH; Li G; Lawton MT; Choudhri O
J Clin Neurosci; 2016 Apr; 26():26-32. PubMed ID: 26857294
[TBL] [Abstract][Full Text] [Related]
18. Enhanced efficacy of combined temozolomide and bromodomain inhibitor therapy for gliomas using targeted nanoparticles.
Lam FC; Morton SW; Wyckoff J; Vu Han TL; Hwang MK; Maffa A; Balkanska-Sinclair E; Yaffe MB; Floyd SR; Hammond PT
Nat Commun; 2018 May; 9(1):1991. PubMed ID: 29777137
[TBL] [Abstract][Full Text] [Related]
19. RVG29-modified docetaxel-loaded nanoparticles for brain-targeted glioma therapy.
Hua H; Zhang X; Mu H; Meng Q; Jiang Y; Wang Y; Lu X; Wang A; Liu S; Zhang Y; Wan Z; Sun K
Int J Pharm; 2018 May; 543(1-2):179-189. PubMed ID: 29555442
[TBL] [Abstract][Full Text] [Related]
20. Local strategies and delivery systems for the treatment of malignant gliomas.
Yu F; Asghar S; Zhang M; Zhang J; Ping Q; Xiao Y
J Drug Target; 2019 Apr; 27(4):367-378. PubMed ID: 30101621
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
